Dr. Yian Du 杜义安
Chief Physician
Department of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and comprehensive treatment of gastric cancer, including minimally invasive, function-preserving, and robotic procedures. Also treats advanced ovarian, liver, pancreatic, gallbladder, and hilar cholangiocarcinoma tumors.
Dr. Du serves as Deputy Director (presiding) of the Gastric Surgery Department and Ward Director at Zhejiang Cancer Hospital. A Chief Physician and master’s supervisor, Dr. Du specializes in upper abdominal tumor surgeries and has extensive clinical experience in comprehensive and conversion therapy for advanced gastric cancer.
Professional roles
- Chair, Gastric Cancer Professional Committee, Zhejiang Society of Mathematical Medicine
- Vice Chair, Tumor Minimally Invasive Diagnosis and Treatment Professional Committee, Zhejiang Anti-Cancer Association
- Standing Committee Member, Chinese Medical Association
- Member, Gastrointestinal Oncology Professional Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Du Yian). Papers usually list the name as Yian Du or Du Y.
Selected publications
66 papers on PubMed matched by name and affiliation; 9 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Immunol, 2026 (senior author): Perioperative PD-1 inhibitor plus chemotherapy versus chemotherapy alone in gastric cancer with PAN metastasis undergoing D2 gastrectomy and PAND: a single-center retrospective cohort study. PubMed 42656747
- J Biol Chem, 2025 (senior author): Exploring the regulatory mechanism of CCNA2 in colorectal cancer: Insights from multiomics and experimental analysis. PubMed 40345591
- Updates Surg, 2024 (senior author): Catheter-guided anvil insertion for circular stapler esophagojejunal anastomosis: a novel technique in laparoscopic total gastrectomy. PubMed 38451410
- J Gastrointest Surg, 2024 (senior author): Prognostic significance of serum tumor markers in various pathologic subtypes of gastric cancer. PubMed 38458911
- J Gastrointest Surg, 2023 (senior author): Comparison of Clinicopathological Features and Prognosis of Mucinous Gastric Carcinoma and other Gastric Cancers: A Retrospective Study of 4,417 Patients. PubMed 37848685
- J Cancer Res Clin Oncol, 2023 (senior author): Hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy versus systemic chemotherapy alone in locally advanced gastric cancer after D2 radical resection: a randomized-controlled study. PubMed 37392201
- Langenbecks Arch Surg, 2023 (senior author): The percentages of signet-ring cells (SRCs) affects the prognosis after radical gastrectomy for advanced gastric cancer. PubMed 37743407
- Cancer Manag Res, 2022 (senior author): Prediction of Peritoneal Cancer Index and Prognosis in Peritoneal Metastasis of Gastric Cancer Using NLR-PLR-DDI Score: A Retrospective Study. PubMed 35046725
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion